welcome to STERNA BIOLOGICALS

sterna biologicals is a clinical-stage immunology company developing novel treatments for chronic inflammatory diseases such as atopic dermatitis, ulcerative colitis, asthma & chronic obstructive pulmonary disease (COPD).

Our Approach

By targeting GATA-3, a key master transcription factor that plays a central role in chronic inflammatory diseases, the company’s proprietary DNAzyme-based drug candidate, hgd40, antagonizes several inflammatory processes and mediators.

Our Mission

Developing innovative, safe and efficacious GATA-3 specific therapies for patients suffering from chronic inflammatory diseases.

Management

Konstantin Petropoulos

Konstantin PetropoulosChief Executive Officer/Managing Director

Konstantin joined sterna as CEO in June 2023. In addition to his role at sterna, he also serves as CBO of Secarna Pharmaceuticals. Prior to this, he was CEO of AMW, a revenue-generating specialty pharmaceuticals company. Over the last 15 years, Konstantin has held senior management positions at several biotech and pharma companies including Bayer, MorphoSys and Leukocare.

Konstantin has a Ph.D. in oncology from the Ludwig-Maximilians-University, Munich, Germany and holds an MBA from the University of Applied Sciences for Economics and Management.

Thomas Klaue

Thomas KlaueChief Financial Officer (consulting)

Before joining sterna biologicals in 2022, Thomas served as Chief Financial Officer and deputy Chief Executive Officer at several publicly listed companies including MK AG and Medigene AG. Thomas was an Assistant Professor at the University of Mannheim in Germany and a Research Fellow at the M.I.T. Sloan School of Management in Boston, where his research focused on innovation management and organizational changes in industrial corporations.

Thomas holds a Ph.D. in Business Economics (Mannheim) and a M. Eng. (K.I.T.) and is a Harvard Business School graduate.

PartneringCreating new opportunities for collaboration

With over a decade of experience in research and development in the field of DNAzymes and immunology sterna biologicals has built a wealth of knowledge in the industry as well as an extensive network of academic and commercial partnerships.

If you are interested in partnering, please contact us at partnering@sterna-biologicals.com. We look forward to hearing from you.